Back
Safety and efficacy of pemetrexed in gynecologic cancers: A systematic literature review
David Scott Miller, Datchen Fritz Tai, Coleman Obasaju, Ignace Vergote
Mod. Chemother. Vol.2 No.2, April 15, 2013  DOI: 10.4236/mc.2013.22004
       (PDF  333K)     HTML      XML
Prospective Analysis of Patients Treated with Chemotherapy in Metastatic Adenocarcinoma of Lung—Single Centre Experience
B. J. Srinivasa, L. P. Bhanu, Girish Badarke, Mohammad Nasiruddin, Sulav Sapkota, D. Tousif, Vishal Kulkarni, P. K. Kiran, Vinu Sarathy, G. S. Deepika, Amritanshu Ram, Raghavendra Rao, Shekar Patil, Radheshyam Naik
J. Cancer Ther. Vol.8 No.9, September 20, 2017  DOI: 10.4236/jct.2017.89073
       (PDF  1033K)     HTML      XML
Good Response to Pemetrexed after Treatment Failure with Another Thymidylate Synthase Inhibitor in Lung Adenocarcinoma: A Case Report
Fumihiko Hirai, Eiko Inamasu, Gouji Toyokawa, Tsukihisa Yoshida, Kaname Nosaki, Tomoyoshi Takenaka, Masafumi Yamaguchi, Mitsuhiro Takenoyama, Takashi Seto, Yukito Ichinose
J. Cancer Ther. Vol.5 No.8, July 10, 2014  DOI: 10.4236/jct.2014.58085
       (PDF  1141K)     HTML      XML
The Role of Thymidylate Synthase in Pemetrexed-Resistant Malignant Pleural Mesothelioma Cells
Tohru Obata, Motohiro Tanaka, Yuka Suzuki, Takuma Sasaki
J. Cancer Ther. Vol.4 No.6, July 17, 2013  DOI: 10.4236/jct.2013.46119
       (PDF  508K)     HTML     
The Clinical Investigation of Pemetrexed Plus Carboplatin as an Active and Tolerable Treatment Plan in Chinese Elderly Patients with Advanced Lung Adenocarcinoma
Yu-Quan Wu, Jun Yang, Xi-Jian Zhou, Peng Li, Xiao-Qiang Fan, Guang-Zhou Lu, Yan-Juan Pan, Xiang-Yong Li, Fu-Lin Yan
J. Cancer Ther. Vol.2 No.3, August 08, 2011  DOI: 10.4236/jct.2011.23042
       (PDF  184K)     HTML     
 
 
Top